| Basics |
|
NORTHWEST BIOTHERAPEUTICS INC |
| IPO Date: |
January 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.82%
|
| Avg Daily Range (30 D): |
$0.01 | 4.24%
|
| Avg Daily Range (90 D): |
$0.02 | 7.23%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.78M |
| Avg Daily Volume (30 D): |
2.33M |
| Avg Daily Volume (90 D): |
3.21M |
| Trade Size |
| Avg Trade Size (Sh.): |
878 |
| Avg Trade Size (Sh.) (30 D): |
5,016 |
| Avg Trade Size (Sh.) (90 D): |
4,671 |
| Institutional Trades |
| Total Inst.Trades: |
48 |
| Avg Inst. Trade: |
$1.49M |
| Avg Inst. Trade (30 D): |
$.55M |
| Avg Inst. Trade (90 D): |
$.55M |
| Avg Inst. Trade Volume: |
.34M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.47M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
617.26K |
|
|
| Financials |
| |
TTM |
Q4 2024 |
Q1 2024 |
|
Basic EPS
|
$-.07
|
$-.02
|
$-.02
|
|
Diluted EPS
|
$-.07
|
$-.02
|
$-.02
|
|
Revenue
|
$ 1.47M
|
$ .23M
|
$ .28M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -84.74M
|
$ -28.2M
|
$ -18.3M
|
|
Operating Income / Loss
|
$ -68.08M
|
$ -18.5M
|
$ -15.74M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 1.54M
|
$ -4.32M
|
$ -.56M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 26, 2012:
1:16
|
|
Jun 28, 2007:
1:15
|
|
|
|
